Tocilizumab Stabilizes Renal Function in Kidney Transplant Recipients with Chronic Active Antibody Mediated Rejection (CAAMR).

被引：0
|
作者：
Patel, S. [1 ]
Mohan, S. [1 ]
Fernandez, H. [1 ]
Batal, I. [1 ]
Ratner, L. [1 ]
Crew, J. [1 ]
机构：
[1] Columbia Univ, New York, NY USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2018年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
205
引用
收藏
页码：326 / 326
页数：1
相关论文
共 50 条
  • [31] EVALUATION OF CLAZAKIZUMAB (ANTI-IL-6) FOR TREATMENT OF KIDNEY TRANSPLANT RECIPIENTS WITH CHRONIC & ACTIVE ANTIBODY MEDIATED REJECTION
    Jordan, Stanley
    Ammerman, Noriko
    Toyoda, Mieko
    Huang, Edmund
    Nast, Cynthia
    Peng, Alice
    Sethi, Supreet
    Najjar, Reiad
    Kim, Irene
    Lim, Kathlyn
    Choi, Jua
    Vo, Ashley
    [J]. TRANSPLANT INTERNATIONAL, 2019, 32 : 400 - 401
  • [32] Potential urinary extracellular vesicle protein biomarkers of chronic active antibody-mediated rejection in kidney transplant recipients
    Jung, Hee-Yeon
    Lee, Chan-Hyeong
    Choi, Ji-Young
    Cho, Jang-Hee
    Park, Sun-Hee
    Kim, Yong -Lim
    Moon, Pyong-Gon
    Baek, Moon -Chang
    Park, Jae Berm
    Kim, Yeong Hoon
    Chung, Byung Ha
    Lee, Sang-Ho
    Kim, Chan-Duck
    [J]. JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2020, 1138
  • [33] Clinical Significance and Therapeutic Potential of Orosomucoid 1 for Chronic Active Antibody Mediated Rejection in Kidney Transplant Recipients.
    Higuchi, H.
    Hotta, K.
    Iwami, D.
    Jiang, J-J.
    Kamimura, D.
    Arima, Y.
    Atsumi, T.
    Takada, Y.
    Harada, H.
    Murakami, M.
    Shinohara, N.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 : 485 - 485
  • [34] GRAFT SURVIVAL OF CHRONIC ACTIVE ANTIBODY-MEDIATED REJECTION IN KIDNEY TRANSPLANT RECIPIENTS: A SINGLE-CENTER STUDY
    Kaeoperm, Pichaya
    Homkrailas, Piyavadee
    [J]. NEPHROLOGY, 2023, 28 : 77 - 77
  • [35] Tocilizumab as Treatment for Persistent Chronic Active Antibody Mediated Rejection.
    Fernandez, H.
    Patel, S.
    Chiles, M.
    Ratner, L.
    Crew, R.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 : 606 - 606
  • [36] Treatment of Chronic Active Antibody-Mediated Kidney Transplant Rejection With Intravenous Immunoglobulin
    Rapetskaya, Nadzeya
    Komissarov, Kirill
    Kalachyk, Aleh
    [J]. TRANSPLANTATION, 2022, 106 (09) : S572 - S572
  • [37] To Treat or Not To Treat: Late Antibody Mediated Rejection in Kidney Transplant Recipients
    Diskin, D.
    Williams, T.
    Reed, R.
    Locke, J.
    Mannon, R.
    Gaston, R.
    Kumar, V.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 436 - 436
  • [38] Retrospective Analysis of Kidney Transplant Recipients with Antibody-Mediated Rejection
    Pineiro, G.
    Desousa, E.
    Villarreal, J.
    Lozano, M.
    Cid, J.
    Sole, M.
    Oppenheimer, F.
    Diekmann, F.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2017, 17 : 536 - 536
  • [39] To Treat or Not To Treat: Late Antibody Mediated Rejection in Kidney Transplant Recipients
    Diskin, D.
    Williams, T.
    Reed, R.
    Locke, J.
    Mannon, R.
    Gaston, R.
    Kumar, V.
    [J]. TRANSPLANTATION, 2014, 98 : 436 - 436
  • [40] Tocilizumab Use in Chronic Active Antibody Mediated Rejection (caamr): Mitigating Risks with Surveillance Donor Derived Cell Free Dna and Low Dose Strategy
    Sanchez-Garcia, J.
    Isom, A.
    Bryan, J.
    Dillon, B.
    Zafar, Z.
    Morris, D.
    Anand, S.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2023, 23 (06) : S488 - S489
12345